Why Is Lexeo Therapeutics Stock Gaining Monday?

Lexeo Therapeutics Inc. (NASDAQ:LXEO) stock rose Monday as the company announced a regulatory update regarding its pivotal SUNRISE-FA 2 trial for gene therapy candidate LX2006. LXEO Stock Jumps The gene therapy company finalized the protocol for its SUNRISE-FA 2...

Fiserv CEO Abruptly Exits For Truist, Stock Tanks

Fiserv, Inc. (NASDAQ:FISV) stock fell nearly 8% on Monday after the payments and financial technology company announced a leadership transition, even as it reaffirmed its full-year 2026 outlook. Takis Georgakopoulos Named CEO Fiserv said Takis Georgakopoulos was...